The standout funding event was the RMB 500 million Series A+ round secu.....
A
A
A
China Biopharma Tracker – November 2025
·12/09/2025
In November 2025, Chinese biotech companies recorded 22 financing deals in total. Among them, 17 firms that disclosed their funding amounts raised an aggregate of USD 367 million, marking a decrease from the USD 420 million raised in October.
The standout funding event was the RMB 500 million Series A+ round secu.....
The standout funding event was the RMB 500 million Series A+ round secu.....
Article keywords： fundraisingReprogenix BioscienceIVACTA BiotechnologyDeliNova TherapeuticsVigonvita Life SciencesLaekna LTZ Therapeutics
Keep reading PharmaDJ with a free subscription
More information about China's pharmaceutical industry